Press release from GlobeNewswire (a Nasdaq OMX company)
CORRECTION: Athersys to Present at 25th Annual Piper Jaffray Healthcare Conference
Monday, November 25, 2013
CORRECTION: Athersys to Present at 25th Annual Piper Jaffray Healthcare Conference13:20 EST Monday, November 25, 2013
CLEVELAND, Nov. 25, 2013 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that the Company will present at the 25th Annual Piper Jaffray Healthcare Conference taking place at The New York Palace on December 3rd and 4th, 2013 in New York City.
In a release issued earlier this afternoon, we mistakenly listed the time of William (B.J.) Lehmann's presentation as December 4, 2013 at 4:00 pm. William (B.J.) Lehmann, President and Chief Operating Officer, will in fact present on Wednesday, December 4, 2013 at 8:30 a.m. Eastern Standard Time.
During the presentation, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to the live audio webcast of the presentation during the event, please visit: www.athersys.com. A replay of the webcast will be available for 30 days after the initial presentation.
Athersys is a clinical stage biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product platform for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas. The Company currently has several clinical stage programs involving MultiStem, including for treating inflammatory bowel disease, ischemic stroke, damage caused by myocardial infarction, and for the prevention of graft-versus-host disease. Athersys has also developed a diverse portfolio that includes other technologies and product development opportunities, and has forged strategic partnerships and collaborations with leading pharmaceutical and biotechnology companies, as well as world-renowned research institutions in the United States and Europe to further develop its platform and products. More information is available at www.athersys.com.
The Athersys, Inc. logo is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=4548
CONTACT: William (B.J.) Lehmann, J.D. President and Chief Operating Officer Tel: (216) 431-9900 email@example.com Investor Relations: Lisa M. Wilson In-Site Communications Tel: (917) 543-9932 firstname.lastname@example.org